4.7 Review

Multiple Factors Causing Myopia and the Possible Treatments: A Mini Review

Journal

FRONTIERS IN PUBLIC HEALTH
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fpubh.2022.897600

Keywords

myopia; anthropometrics; Asian; axial length (AL); treatments

Ask authors/readers for more resources

The myopia epidemic is a global public health problem, and the COVID-19 outbreak has accelerated its progression. Current treatments for humans include eye drops, optical treatment, and orthokeratology, while animal experiments have revealed new mechanisms of myopia suppression.
The myopia epidemic has become a global public health problem. Although myopia is progressing worldwide, the recent coronavirus infections 2019 (COVID-19) outbreak has spurred myopia progression. The current evidence-based treatments for humans are atropine eye drops, optical treatment with defocus, use of orthokeratology, extending proximity working distance, pausing from near work every half hour and increased time outside the home. Studies on myopia using animal models have been conducted for more than 40 years. In recent years, new mechanisms of myopia suppression have been revealed from animal experiments such as inflammation control, intraocular pressure control, light control, and the activity of early growth response protein 1 control. This mini-review provides a summary of the scientific evidence currently available on the control of myopia, and the possible treatments mitigating myopia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available